 |
Kendle
International
Kendle International (KNDL) hails from the
Medical-Dental Services industry group, ranked No. 18
among IBD's
197 groups. Kendle does clinical trials for
pharmaceutical and biotech companies. It's based in
Cincinnati, but operates in 28 countries. It's featured
in one of the mini company profiles in today's IBD 100
section.
- Kendle is a small cap, with a market
capitalization of $684 million.
- It trades 251,000 shares a day. As often noted in
the DSAs, stocks trading under 300,000 shares a day
can be more volatile than more widely traded issues.
- It recently reported earnings of 52 cents a share,
up 79% from the same quarter a year ago.
- Mutual fund ownership has increased in each of the
past three quarters.
- Kendle's Accumulation/Distribution Rating is A-,
showing a healthy level of buying in the past 13
weeks.
|
|
|
|
 |
|
|
 |
|
Stocks
being BOUGHT
heavily by institutional investors. |
|
|
|
|
Stock Symbol |
|
Price |
Price
Chg |
Vol % Chng |
|
|
|
| |
KNSY |
|
37.70 |
+1.22 |
+220 |
|
|
|
| |
LDK |
|
50.06 |
+4.24 |
+144 |
|
|
|
| |
CRM |
|
56.53 |
+0.56 |
+59 |
|
|
|
| |
THOR |
|
25.37 |
+0.50 |
+36 |
|
|
|
| |
JRJC |
|
18.45 |
+1.09 |
+35 |
|
|
|
 |
|
|
|
| Advertisement |
| | |
|
